Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line
- PMID: 3191488
Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line
Abstract
Previous work indicated that transforming growth factor-beta (TGF-beta) elicits proliferation-inhibitory effects in the human colon carcinoma cell line MOSER. This paper describes the isolation and characterization of spontaneously arising subclones from this TGF-beta-sensitive parental line which were relatively refractory to the inhibitory effects of TGF-beta. While the parental cell line responded to TGF-beta with an inhibition of cellular proliferation in monolayer culture and in soft agarose, an increase in extracellular fibronectin, and a down-regulation of c-myc protooncogene expression, these responses were absent or attenuated in the sublines. However, the resistant clones retained the ability to specifically bind TGF-beta. N,N-Dimethylformamide and retinoic acid, two other agents associated with induction of a partial differentiation-like response in the MOSER parental cells (similar to that elicited by TGF-beta), inhibited the monolayer proliferation of both the parental cells and the TGF-beta-resistant sublines. Thus, the refractoriness observed in the isolated clones was relatively specific for TGF-beta.
Similar articles
-
Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.Cancer Res. 1989 Apr 15;49(8):2112-7. Cancer Res. 1989. PMID: 2539253
-
Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.Cancer Res. 1987 Jun 1;47(11):2950-4. Cancer Res. 1987. PMID: 3471320
-
Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.J Cell Physiol. 1989 Mar;138(3):459-66. doi: 10.1002/jcp.1041380304. J Cell Physiol. 1989. PMID: 2925796
-
Transforming growth factor beta isoform-specific differences in interactions with type I and II transforming growth factor beta receptors.Cancer Res. 1995 May 15;55(10):2056-62. Cancer Res. 1995. PMID: 7743502
-
The role for transforming growth factor-beta (TGF-beta) in human cancer.Crit Rev Oncog. 1999;10(4):303-60. Crit Rev Oncog. 1999. PMID: 10654929 Review.
Cited by
-
Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.J Clin Invest. 1995 Dec;96(6):2667-75. doi: 10.1172/JCI118333. J Clin Invest. 1995. PMID: 8675633 Free PMC article.
-
Expression of transforming growth factor beta in renal cell carcinoma and matched non-involved renal tissue.Urol Res. 2004 Oct;32(5):317-22. doi: 10.1007/s00240-003-0360-z. Epub 2004 Sep 7. Urol Res. 2004. PMID: 15365652
-
The role of fibroblasts in tumor behavior.Cancer Metastasis Rev. 1995 Dec;14(4):339-50. doi: 10.1007/BF00690602. Cancer Metastasis Rev. 1995. PMID: 8821094 Review.
-
Overexpression of the dynein light chain km23-1 in human ovarian carcinoma cells inhibits tumor formation in vivo and causes mitotic delay at prometaphase/metaphase.Int J Cancer. 2011 Aug 1;129(3):553-64. doi: 10.1002/ijc.25954. Epub 2011 Apr 25. Int J Cancer. 2011. PMID: 21469138 Free PMC article.
-
Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation.Proc Natl Acad Sci U S A. 1990 May;87(10):3758-62. doi: 10.1073/pnas.87.10.3758. Proc Natl Acad Sci U S A. 1990. PMID: 2187192 Free PMC article.